HBM Healthcare Investments AG

HBMN:SWX

HBM Healthcare Investments AG

Actions
  • Price (CHF)181.40
  • Today's Change-0.20 / -0.11%
  • Shares traded6.71k
  • 1 Year change+7.59%
  • Beta0.9541
Data delayed at least 15 minutes, as of Nov 06 2024 16:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CHF
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments105.735.39
Total Receivables, Net0.060.020.02
Total Inventory------
Prepaid expenses------
Other current assets, total------
Total current assets105.755.41
Property, plant & equipment, net------
Goodwill, net------
Intangibles, net------
Long term investments1,7961,9182,132
Note receivable - long term------
Other long term assets------
Total assets1,8071,9242,137
LIABILITIES
Accounts payable------
Accrued expenses------
Notes payable/short-term debt000
Current portion long-term debt/capital leases0500
Other current liabilities, total3.312.172.05
Total current liabilities3.31522.05
Total long term debt9999149
Total debt99149149
Deferred income tax------
Minority interest------
Other liabilities, total------
Total liabilities103151151
SHAREHOLDERS EQUITY
Common stock84136204
Additional paid-in capital------
Retained earnings (accumulated deficit)1,6361,6371,783
Treasury stock - common(16)(0.4)(0.4)
Unrealized gain (loss)------
Other equity, total------
Total equity1,7041,7731,986
Total liabilities & shareholders' equity1,8071,9242,137
Total common shares outstanding6.876.966.96
Treasury shares - common primary issue0.090.000.00
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.